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Abstract 
The regional distribution of adipose tissues is implicated in a wide range of diseases. For 
example, proportional increases in visceral adipose tissue increase the risk for insulin 
resistance, diabetes and cardiovascular disease. Zebrafish offer a tractable model system 
by which to obtain unbiased and quantitative phenotypic information on regional adiposity, 
and deep phenotyping can explore complex disease-related adiposity traits. To facilitate 
deep phenotyping of zebrafish adiposity traits, we used pairwise correlations between 67 
adiposity traits to generate stage-specific adiposity profiles that describe changing 
adiposity patterns and relationships during growth. Linear discriminant analysis classified 
individual fish according to adiposity profile with 87.5% accuracy. Deep phenotyping of 
eight previously uncharacterized zebrafish mutants identified neuropilin 2b as a novel 
gene that alters adipose distribution. When we applied deep phenotyping to identify 
changes in adiposity during diet manipulations, zebrafish that underwent food restriction 
and re-feeding had widespread adiposity changes when compared to continuously-fed, 
equivalently-sized control animals. In particular, internal adipose tissues (e.g., visceral 
adipose) exhibited a reduced capacity to replenish lipid following food restriction. 
Together, these results in zebrafish establish a new deep phenotyping technique as an 
unbiased and quantitative method to help uncover new relationships between genotype, 
diet and adiposity.      
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Introduction 
Adipose tissues (ATs) are lipid-rich organs that supply and sequester circulating 
lipid in response to systemic energy demands. ATs thus provide ‘energetic insurance’ to 
individuals, and confer selective advantages during periods of adverse physiological 
stresses. In modern societies, where food availability is high and energy expenditure is 
low, ATs accumulate large quantities of lipid which can initiate a range of secondary 
metabolic abnormalities that result in increased susceptibility to diabetes, cardiovascular 
disease (CVD) and cancer. A wide-range of adiposity traits can influence disease risk. 
For example, general adiposity levels, as measured by body mass index (BMI), are 
associated with increased risk for disease (1). In turn, the regional distribution of AT can 
also influence disease risk. For example, accumulation of visceral adipose tissue (VAT) 
in the abdominal cavity in close proximity to visceral organs, is associated with an 
increased risk for insulin resistance and a sequelae of accompanying diseases such as 
diabetes and CVD (2, 3). Conversely, accumulation of subcutaneous adipose tissue 
(SAT) in a peripheral location at the hips and upper thighs, is associated with reduced 
disease risk (4). Understanding how genetics and the environment influence these 
diverse adiposity traits will be key to treating and predicting the metabolic consequences 
of obesity.  
Zebrafish are a tropical freshwater fish that offer a tractable model system to study 
AT biology. Zebrafish AT is morphologically and molecularly homologous to mammalian 
white adipose tissue (5, 6). Zebrafish AT also appears to be functionally conserved to 
mammalian WAT and accumulates lipid during periods of chronic energy excess, and 
mobilizes lipid during energy deficiency (5, 7, 8). The molecular pathways that regulate 
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adiposity also appear to be conserved between zebrafish and mammals, as typified by 
zebrafish growth hormone (gh) mutants (9). Importantly, zebrafish AT can be visualized 
and quantified in vivo at both cell and whole-animal resolutions (10, 11). We recently 
utilized these imaging properties to comprehensively identify, characterize and quantify 
the full complement of zebrafish ATs at distinct developmental stages (7). This 
methodology generates unbiased and quantitative phenotypic information on a 
comprehensive range of adiposity traits. We reasoned that such multivariate data could 
be utilized for deep phenotyping of adiposity traits. Briefly, deep phenotyping is defined 
as the precise and comprehensive analysis of phenotypic abnormalities (12), and is useful 
for identifying traits and complex phenotypic signatures that define health or disease (13-
15). Deep phenotyping is particularly powerful when such traits may be quantitative and 
subtle, as found with adiposity.  
In this study, we generated stage-specific adiposity profiles that comprehensively 
capture patterns and relationships in adiposity dynamics and adipose distribution. To 
classify individuals according to expected patterns of adiposity, we applied linear 
discriminant analysis (LDA) to the adiposity profiles. We utilized this methodology to 
screen eight zebrafish mutants, and identified neuropilin 2b (nrp2b) as a novel gene that 
promotes adiposity in zebrafish. Finally, we applied our deep phenotyping strategy to 
identify adiposity changes that occur following diet manipulation. We identified that food 
restriction induced profound changes in fat distribution even after animals had fully re-
gained weight. Closer analysis revealed that Internal ATs (IATs), including VAT, did not 
fully re-gain lipid following re-feeding resulting in altered fat distribution. Altogether, we 
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develop methodology to quantitatively extract phenotypic information for detecting gene 
and diet-induced adiposity phenotypes.  
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Materials & Methods 
Zebrafish husbandry, strains and data availability 
Zebrafish experiments conformed to the U.S. Public Health Service Policy on the 
Humane Care and Use of Laboratory Animals, using protocols approved by the 
Institutional Animal Care and Use Committees of the University of North Carolina at 
Chapel Hill (UNC) and Duke University. Zebrafish husbandry for experiments conducted 
at either UNC or Duke were performed as previously described (7). The Ekkwill (EKW) 
and WIK wild-type data used as the LDA training set (N = 456) was previously published 
(7), and is available for download at DataDryad (DOI: 
https://doi.org/10.5061/dryad.98470). The gh mutant data used as a positive control for 
LDA were previously published (9) and raw images are available for download at 
DataDryad (***not yet deposited***). The eight zebrafish mutants used for LDA were 
obtained from the Wellcome Trust Sanger Institute’s Zebrafish Mutation Project (ZMP) or 
from ZIRC (16). Embryos were received at Duke on a Hubrecht long-fin background 
(HLF). Incrosses were performed between heterozygous individuals to generate 
experimental clutches. Genotypes were determined by Sanger sequencing. Images used 
for quantification are deposited at DataDryad (***not yet deposited***). All alleles used in 
this study are included in Table 1. The food restriction and re-feeding was performed in 
EKW wild-type fish at Duke and the raw images are available for download at DataDryad 
(***not yet deposited***). 
 
Nile Red staining, image analysis, adipose and stage classification 
Minchin et al. 
 
7 
 
Nile Red (Sigma-Aldrich, #N1142) was dissolved in acetone at 1.25 mg/ml and 
diluted to 0.5 µg/ml in system water for lipid staining (10, 11). Zebrafish were incubated 
in the diluted Nile Red for 30 minutes as previously described (10, 11). Following the 
staining, melanosomes were contracted by incubation in 10 mg/ml epinephrine (Sigma-
Aldrich, #E4375) for 5 minutes, and zebrafish were anaesthetized in 1.34 g/L MS222 
(Sigma-Aldrich, #A5040) for 3 minutes and mounted on 3% methylcellulose (Sigma-
Aldrich, #MO387). The right-hand side of each fish was imaged on a Leica MZ205FA 
fluorescence stereomicroscope equipped with a Leica DFC365 FX fluorescence camera, 
and using a GFP2 bandpass filter (Leica Microsystems, #10447407). All analyses were 
conducted in FIJI/ImageJ (v1.51i) (17). For AT area measurements, two copies of each 
image were opened; one for taking measurements, and one for comparisons to maximize 
accuracy of adipose segmentation. Standard length (SL), height at the anterior margin of 
the anal fin (HAA), and body area were used to determine zebrafish size and were 
measured using the line and polygon tools as previously described (7, 18). AT areas were 
defined by manually set thresholds based on pixel intensities (7). For ATs that did not 
touch, the magic wand tool was used to select AT area. For touching ATs, the polygon 
tool was used to trace the AT outline, and where a dividing line between the ATs was not 
visible, a straight line was drawn between the farthest distinguishing AT points. Lateral 
view images were used for all measurements. ATs were classified and measured as 
described here (7). A schematic illustrating the location of each AT in zebrafish is included 
in Supplemental Figure 1. The stages used for generating adiposity profiles incorporated 
both postembryonic and adiposity milestones as previously documented (7, 18). As 
previously described, Nile Red also labels neutral lipid within the liver, intestinal 
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epithelium and the blood (5, 7); however, lipid at these sites can be readily distinguished 
from AT. Adiposity measurements used in this study are included in Supplemental 
Tables 1 and 2. 
 
Food restriction and re-feeding experiments 
Food restriction and re-feeding experiments were conducted largely as described 
(5), with the following differences; zebrafish at 38 days post fertilization (11.4 ± 0.5 mm 
SL (mean ± standard deviation); DFRSAT stage) were housed individually in six-well 
plates containing ~3 ml of system water. No food was administered during food restriction 
(days 1–11). Upon re-feeding (days 12–22), fish were fed Artemia franciscana and 
powdered food as per normal husbandry procedures at Duke University as previously 
described (7). Every 24 hours, 0.5 µg/ml Nile Red was added to the wells, and the 
fluorescent lipid signal was imaged on a Leica MZ205FA fluorescence stereomicroscope 
equipped with a Leica DFC365 FX fluorescence camera as described above. Lipid 
deposits were thus evaluated daily and food restriction was stopped after 11 days once 
lipid was mobilized from all AT sites in all animals. System water was replaced daily during 
both starvation and re-feeding periods.  
 
Statistical analyses 
Stage-specific adiposity profiles were generated using pairwise correlations 
between 63 adiposity traits (listed in Table 2) using the multivariate platform in JMP Pro 
13 (SAS, NC). Adiposity profiles were constructed for 14 stages (Supplemental Figure 
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2 and Supplemental Tables 3-16). Heatmaps to visualize the adiposity profiles were 
generated in JMP and show pairwise inter-trait correlations expressed as the Pearson’s 
correlation coefficient (1 is a total positive correlation between traits, 0 is no correlation, -
1 is a total inverse correlation). LDA was performed to classify individual fish according 
to their adiposity profiles. LDA was performed in JMP using the discriminant analysis 
platform and a linear common covariance method. LDA is a general linear model that 
derives discriminant functions - linear combinations of variables - to maximize the 
probability of assigning observations to a pre-defined group. The discriminant functions 
for each group (adiposity profile) (Cprofile) followed (19, 20), and are expressed as: Cprofile 
= i + c1(log10 a1) + c2(log10 a2) + ··· + cn(log10 an) where c is the coefficient of the 
classification equation (19), i is the constant for each group (adiposity profile) as 
determined by multiplying the matrix of classification coefficients for that group by the 
matrix of means for each adiposity trait variable (a) of that group. All 63 adiposity traits 
were used as variables for LDA. To define the adiposity characteristics, adiposity profiles 
from 456 wild-type fish were set as a validation group (training set). Analysis of inter-
clutch variability in LDA within the training set revealed misclassification rates of 15.2% 
(mean) with a standard error (SE) of 2.4% (25 independent clutches). This baseline rate 
was used to identify phenotypic fish during additional comparisons. We defined ‘non-
normal’ phenotypes if clutches had a % misclassification rate >3 ± SE from the training 
set rate. These clutches were evaluated further as phenotypic. Principal components 
analysis (PCA) of adiposity profiles during food restriction (days 1-11) and re-feeding 
(days 12-22) was conducted in JMP using the default estimation method. The mean 
recovery, or re-gain, of AT-lipid at day 22 (following food restriction and re-feeding) was 
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calculated as a % of AT-lipid at day 1. Hierarchical clustering of AT-lipid re-gain at day 22 
was performed in JMP using the Ward method (21). Student’s t-tests were used for 
pairwise comparisons, and one-way ANOVA followed by Tukey’s post-hoc test used for 
multiple groups. ANCOVA was used to test for differences between groups following 
linear regression. Statistical significance was set to alpha = 0.05. Graphs were plotted in 
R using ggplot2 (22, 23). The stage-specific adiposity profiles can be found in 
Supplemental Figure 2 and the accompanying correlation matrices in Supplemental 
Tables 3-18 
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Results 
Stage-specific phenotypic profiles capture adiposity patterns and relationships 
Whole-animal in vivo imaging in zebrafish enables the quantification of all ATs in 
a single animal and can thus be used to reveal a wide range of adiposity traits, including 
changes in fat levels, ectopic localization to specific organs and changes in regional 
distribution (5, 10, 11). We reasoned that collecting large amounts of quantitative 
adiposity data could be used to classify individuals based on adiposity traits and identify 
subtle, quantitative adiposity phenotypes. We previously showed that stage-matched 
zebrafish exhibit stereotypical adiposity patterns (Fig. 1A) (7). Therefore, we utilized 
existing data to generate stage-specific phenotypic profiles that capture adiposity 
information (hereafter called adiposity profiles). In total, 456 wild-type zebrafish across a 
range of sizes, stages and ages were used to construct adiposity profiles (Fig. 1B) (7). 
From these 456 fish, 67 traits were quantified in each fish (Table 1). The 67 traits included 
(i) AT area measurements, (ii) measures of body size (including SL, HAA, body area), (iii) 
composite AT groupings (e.g., total AT, SAT, VAT), and (iv) AT proportionality 
assessments (e.g., VAT:SAT). Correlations were computed between each trait and 
assessed to determine how adiposity relationships and patterns change in fish of distinct 
stages (Fig. 1B). As expected, considerable differences were observed in adiposity 
profiles at distinct stages (Fig. 1B & C). For example, Pancreatic VAT (PVAT) was initially 
positively correlated with SL (stage PB), before becoming progressively more inversely 
correlated with SL in larger fish (stage SA) (Fig. 1C). In conclusion, adiposity profiles 
capture dynamic changes in adiposity patterns at distinct developmental stages and will 
be useful indicators of ‘normal’ adiposity levels and variation. 
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Linear discriminant analysis accurately classifies zebrafish according to the 
adiposity profile 
To effectively use stage-specific adiposity profiles as a base for in-depth 
phenotypic profiling we utilized linear discriminant analysis (LDA). LDA is a data 
dimensionality reduction technique that can assign membership of a group based on 
accompanying covariate values. LDA has been used previously to (i) classify 
morphological phenotypes into distinct groups (24, 25), (ii) predict disease outcomes 
based on current symptoms (26), and (iii) predict future business success based on 
current financial parameters (27). We reasoned that LDA could also be applied to 
adiposity profiles and used to classify individual fish according to expected adiposity traits. 
As a training set, we applied the adiposity profiles from the 456 wild-type fish described 
above and assessed whether LDA was able to accurately assign fish to correct 
developmental stages (Fig. 2A). Based on adiposity profiles, LDA assigned 87.5% of the 
wild-type fish into correct stages (Fig. 2A). We next assessed how robust the LDA 
classification method was across multiple independent clutches. We divided the training 
set data into its 25 constituent clutches and applied LDA to each clutch, resulting in an 
average classification rate of 84.8 ± 2.4% (mean ± SE) (Fig. 2E). Next, as a proof-of-
concept, we used zebrafish growth hormone (gh) mutants to determine if LDA can be 
used to detect adiposity phenotypes. We previously showed that gh mutants have 
increased adiposity and retarded somatic growth relative to size-matched wild-type 
siblings (Fig. 2B & C) (9). From McMenamin et al. we applied LDA to the adiposity profiles 
of 62 homozygous gh mutants and 60 wild-type siblings from three clutches (Fig. 2D). 
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Adiposity profiles from the 456 wild-type zebrafish were used as a training set (Fig. 2D). 
Within the training set, LDA identified 15.2% of animals as phenotypic, setting a low 
background misclassification rate (Fig. 2E). From the gh mutant-only data, LDA correctly 
identified phenotypes based on adiposity profiles in 60% of cases (Fig. 2E). However, 
when the clutch was considered as a whole (containing both wild-type siblings and 
mutants), LDA classified 36% of individuals as phenotypic (P = 0.003) (Fig. 2E). Based 
on the genotype data, the true misclassification rate was expected to be 50.8%; therefore, 
although LDA was underperforming, it could be effectively used to flag the clutch as 
phenotypic. Taken together, LDA can be used to identify phenotypic adiposity traits based 
on adiposity profiles. 
 
Identification of nrp2b as a novel gene implicated in zebrafish adiposity 
We next sought to apply LDA to help identify novel zebrafish adipose mutants. We 
obtained eight mutant lines generated by the Zebrafish Mutation Project (ZMP) (Table 1) 
(16). The eight ZMP mutants were selected as candidate regulators of adiposity based 
on published experimental evidence or by genome-wide association studies (28-35). 
Heterozygous carriers from the ZMP mutants were intercrossed, the offspring raised to 
~30 days post fertilization (dpf) and then Nile Red was used to visualize AT levels (Fig. 
3). Following imaging, the fish were genotyped to identify wild-type, heterozygous and 
homozygous mutants. Adiposity profiles were constructed for each fish, and LDA used to 
identify differences in adiposity relative to the training set of 465 wild-type fish. Of the 
eight ZMP mutant lines, only nrp2b robustly presented mutant identification rates higher 
than expected from wild-type fish (Fig. 3A), suggesting that mutation of nrp2b may 
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influence adiposity in zebrafish.  The other seven lines all exhibited misclassification rates 
within the expected wild-type range and were therefore classed as phenotypically normal 
(Fig. 3A). Closer analysis of the nrp2b fish stained by Nile Red revealed a robust 
reduction in total adiposity, which was validated by analyzing two additional and 
independent clutches (Fig. 3B & C). In conclusion, we utilized LDA to screen eight new 
zebrafish mutants for adiposity phenotypes and identified nrp2b as a potential novel 
modifier of adiposity.  
 
Linear discriminant analysis identifies differences in adiposity traits following food 
restriction and re-feeding 
We reasoned that adiposity profiles and analysis by LDA could also be applied to identify 
diet-induced changes in adiposity. To test this, we subjected zebrafish to prolonged food 
restriction followed by re-feeding until total adiposity levels were completely replenished. 
Previous studies have shown that zebrafish robustly mobilize and re-gain AT-localized 
lipid in response to food levels (5). Further, zebrafish recover from acute food restriction 
with no visible health detriments (5). We subjected 10 wild-type (EKW) zebrafish to 
complete food restriction for 11 days, followed by 11 days of re-feeding (Fig. 4). To build 
an accurate depiction of adiposity dynamics, the fish were stained with Nile Red and their 
AT-localized lipid imaged daily during the course of the diet manipulation (Fig. 4A). AT-
localized lipid was fully mobilized by 11 days of food restriction, as judged by the lack of 
Nile Red+ lipid within adipose tissue (Fig. 4A). At this point, zebrafish were re-fed a 
normal diet (see Methods) until total adiposity had reached levels equivalent to size-
matched normally-fed individuals (Figs. 4A and 5A). Adiposity profiles were generated 
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for each fish at each day of diet manipulation (day 1 – 22), and principal components 
analysis (PCA) was used to identify whether adiposity trait dynamics were different during 
food restriction and re-feeding (Fig. 4B & C). Strikingly, PCA traced distinct trajectories 
for food restricted and re-fed zebrafish which did not overlap (Fig. 4B & C), suggesting 
that food restriction and re-feeding elicits changes in AT distribution even after complete 
recovery of total AT levels. We next applied LDA to determine if adiposity profiles differed 
after food restriction and re-feeding. We generated adiposity profiles of fully re-fed 
animals (day 22) and ‘continuously fed’ animals that were matched for both size (SL) and 
developmental stage (Fig. 5B and Supplemental Tables 17 & 18). LDA misclassified 
~90% of food restricted and re-fed zebrafish (day 22) when compared with stage-matched 
control animals (Fig. 5C). Thus food restriction and re-feeding leads to wide-ranging 
adiposity differences relative to normally fed animals.     
 
Differential capacities to replenish lipid post-food restriction lead to fat distribution 
differences in zebrafish 
As food restriction and re-feeding alters fat distribution even after total adiposity 
levels have been restored, we next closely assessed how individual ATs responded to 
diet manipulation. We previously identified 34 regionally distinct zebrafish ATs that could 
be classified into two main divisions; ‘internal’ (IAT), which contains the VAT, and SAT 
(7). Calculation of the % recovery of each AT (day 22 levels relative to day 1 levels) 
revealed that IATs had a more limited capacity to replenish lipid when compared to SAT 
(Fig. 6A). The exception to this was cardiac VAT (CVAT) which exhibited very high levels 
of lipid replenishment following re-feeding (Fig. 6A). When food restricted and re-fed 
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animals (day 22) were compared to size-matched ‘continuously-fed’ animals it become 
clear that IAT was unable to recover lipid levels to wild-type levels (Fig. 6B), whereas, 
SAT exhibited robust levels of replenishment to wild-type levels (Fig. 6C). Indeed, the 
average IAT recovery was ~80%, whereas SAT recovery was ~160% (Fig. 6D). These 
distinct capacities to replenish lipid following food restriction and re-feeding resulted in a 
reduced IAT:SAT ratio when compared to stage-matched ‘continuously-fed’ control fish 
(Fig. 6E). Taken together, food restriction and re-feeding led to altered fat distribution 
even after full replenishment of AT levels. These changes were caused by a general 
failure of internal ATs to replenish lipid levels.     
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Discussion 
Deep phenotyping offers considerable potential for the identification of parameters 
that signify health and disease. Comprehensive and quantitative phenotyping methods 
are particularly important for adiposity traits that often exhibit complex and continuous 
phenotypes that are often not adequately assessed by qualitative methods. In this study, 
we utilize in vivo imaging in zebrafish to develop adiposity profiles that capture unique 
patterns and relationships that define an individual’s adiposity. We further employ LDA to 
assign individuals based on adiposity phenotype, and develop this methodology to screen 
for both genetic and diet-induced changes in adiposity.  
Developing quantitative methodology that can robustly evaluate complex 
morphological and functional phenotypic changes is essential for understanding and 
interpreting health and disease states. Most studies have so far focused on ‘large-effect’ 
phenotypes. However, for complex quantitative traits, phenotypes are often subtler (15). 
Adiposity is a continuous, complex, quantitative trait; therefore, suitable phenotyping 
methods are needed. The methodology reported here leverages our recent identification 
and developmental analysis of zebrafish ATs to generate integrated adiposity profiles for 
individuals (7). The adiposity profiles generated in this study, capture the patterns and 
relationships that define an individual’s adiposity, and can thus be used to define 
expected adiposity. LDA represents a tractable strategy to assign individuals to groups 
according to adiposity profile. Indeed, we found that LDA robustly and accurately 
classified individuals with a low basal misclassification rate of 12.5%. gh mutants were 
used as a positive control and LDA was able to classify. Therefore, LDA appears to be a 
robust method to identify multiple aspects of a pleiotropic phenotype. To maximize the 
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deep phenotyping methods described here it will be helpful to develop automated image 
analysis methods. Automating accurate segmentation of zebrafish ATs is challenging, 
owing to their irregular shape; however, the large signal to noise ratio of fluorescent 
lipophilic dyes, such as Nile Red, are ideal reagents to facilitate automated image 
segmentation.  
As a proof-of-principle, we evaluated whether adiposity profiles and LDA were 
useful as phenotyping methods in a genetic screen. In total, we tested eight ZMP mutants 
which have not been previously implicated in adiposity changes. LDA was able to identify 
a single mutant in nrp2b as having an adiposity phenotype. Closer analysis revealed that 
nrp2b has fairly subtle defects in total AT and VAT which were difficult to detect by eye. 
Neuropilins (Nrps) are co-receptors for secreted Semaphorin ligands, and co-bind with 
Plexin receptors. Nrps have been implicated in neurogenesis and angiogenesis (36, 37); 
however, no role has so far been found in adiposity. We recently identified that Plexin D1 
(plxnd1) mutant zebrafish have altered regional adiposity, characterized by reduced 
levels of VAT (38, 39). We speculate that Nrp2b in zebrafish may be involved in Plxnd1-
mediated VAT growth, possibly by facilitating that binding of Sema3 ligands to the Plxnd1 
receptor. Importantly, we did not verify the effect of mutation on the affected gene. This 
was due to keeping the screen higher-throughput, but leads to the caveat that the specific 
alleles tested may not lead to large effects (i.e., loss of transcript or protein) (40). 
Therefore, our results should be interpreted that the tested alleles have no phenotypes, 
but do not necessarily represent the function of the gene. Evaluating adiposity 
phenotypes with additional alleles will be essential for properly determining gene function.  
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As an additional proof-of-principle, we used LDA to assess the effects of food 
restriction and re-feeding to induce widespread adiposity changes. Food restriction and 
re-feeding in mammalian models can lead to AT distribution differences (41, 42). For 
example, calorie restriction or alternate-day fasting in mouse results in preferential 
visceral fat loss (43). In zebrafish, we identified a striking phenotype whereby internal 
ATs, which are mainly composed of VAT, do not fully replenish lipid following re-feeding. 
These changes were evident even in animals with equivalent total levels of AT as normally 
fed individuals. SATs have a greater capacity to re-deposit lipid when compared to VATs, 
and re-fed fish display decreased IAT:SAT ratios. As accumulation of SAT is associated 
with reduced risk of metabolic disease in humans (4) and zebrafish (38), our results raise 
the possibility that the increased SAT accumulation induced by long-term food restriction 
and refeeding may have beneficial health effects. 
In conclusion, we present here a new method to comprehensively assess the 
adiposity phenotype in zebrafish. This methodology takes advantage of the fact that a 
wide range of adiposity traits can be quickly and accurately quantified in live zebrafish, 
thus providing a complete read-out of an individual’s adiposity profile. We anticipate that 
this method will be useful to identify additional new genetic and environmental factors 
governing AT development and physiology.  
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Tables 
Table 1. Zebrafish mutants assessed for adiposity changes in this study 
Gene Gene 
symbol 
Allele Allele 
consequenc
e 
# of fish 
screene
d 
% 
misclassifi
ed 
(‘phenotypi
c’) 
neuropilin 2b nrp2b sa18942 Essential 
splice site 
34 35.3% 
nuclear receptor 
subfamily group a 
member 3 
nr4a3 sa2842 Nonsense 34 14.7% 
proprotein 
convertase 
subtilisin/kexin 
type 1 
pcsk1 sa1558 Essential 
splice site 
33 9% 
semaphorin 3aa sema3aa sa10241 Nonsense 35 14% 
semaphorin 3fb sema3fb sa14466 Nonsense 47 14.8% 
semaphorin 3gb sema3gb sa21283 Nonsense 21 14.2% 
sarcospan sspn sa2992 Nonsense 36 16.7% 
transmembrane 
protein 160 
tmem160 sa1347 Nonsense 29 13.7% 
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growth hormone gh wp22e1 Premature 
stop codon 
130 36% 
 
Table 2. Morphological traits used to construct adiposity profiles. 
Trait Trait acronym Trait category 
Standard length (µm) SL Body size  
Height at anterior of anal fin 
(µm) 
HAA Body size 
Body area (µm2) BA Body size 
Pancreatic VAT (µm2) PVAT AT area 
Abdominal VAT (µm2) AVAT AT area 
Renal VAT (µm2) RVAT AT area 
Cardiac VAT (µm2) CVAT AT grouping 
Anterior CVAT (µm2) aCVAT AT area 
Posterior CVAT (µm2) pCVAT AT area 
Visceral AT (µm2) VAT AT area 
Abdominal SAT (µm2) ASAT AT area 
Lateral SAT (µm2) LSAT AT area 
Dorsal SAT (µm2) DSAT AT grouping 
Anterior DSAT (µm2) aDSAT AT area 
Posterior DSAT (µm2) pDSAT AT area 
Ventral SAT (µm2) VSAT AT area 
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Truncal SAT (µm2) TSAT AT grouping 
Dorsal fin ray SAT (µm2) DFRSAT AT area 
Anal fin ray cluster SAT 
(µm2) 
AFCSAT AT area 
Anal fin ray SAT (µm2) AFRSAT AT area 
Caudal fin ray SAT (µm2) CFRSAT AT area 
Pectoral fin SAT (µm2) PECSAT AT grouping 
Loose PECSAT (µm2) lPECSAT AT area 
Anterior PECSAT (µm2) aPECSAT AT area 
Posterior PECSAT (µm2) pPECSAT AT area 
Appendicular SAT (µm2) APPSAT AT grouping 
Central IM (µm2) cIM AT area 
Dorsal IM (µm2) dIM AT area 
Ventral IM (µm2) vIM AT area 
Intermuscular (µm2) IM AT grouping 
Dorsal POS (µm2) dPOS AT area 
Central POS (µm2) cPOS AT area 
Ventral POS (µm2) vPOS AT area 
Paraosseal (µm2) POS AT grouping 
Oesophageal (µm2) OES AT area 
Non-visceral AT (µm2) NVAT AT grouping 
Dorsal OPC (µm2) dOPC AT area 
Ventral OPC (µm2) vOPC AT area 
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Opercular (µm2) OPC AT grouping 
Ocular (µm2) OCU AT area 
Branchihyal (µm2) BHD AT area 
Ceratohyal (µm2) CHD AT area 
Urihyal (µm2) UHD AT area 
Hyal (µm2) HYD AT grouping 
Cranial SAT (µm2) CSAT AT grouping 
Total AT (µm2) TOTAL AT grouping 
Subcutaneous AT (µm2) SAT AT grouping 
Internal AT (µm2) IAT AT grouping 
 VAT:IAT AT ratio 
 NVAT:IAT AT ratio 
 IAT:TOTAL AT ratio 
 SAT:TOTAL AT ratio 
 CSAT:SAT AT ratio 
 APPSAT:SAT AT ratio 
 TSAT:SAT AT ratio 
 VAT:SAT AT ratio 
 NVAT:SAT AT ratio 
 CSAT:IAT AT ratio 
 TSAT:IAT AT ratio 
 APPSAT:IAT AT ratio 
 VAT:TSAT AT ratio 
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 VAT:CSAT AT ratio 
 VAT:APPSAT AT ratio 
 NVAT:TSAT AT ratio 
 NVAT:CSAT AT ratio 
 NVAT:APPSAT AT ratio 
 NVAT:VAT AT ratio 
 TSAT:CSAT AT ratio 
 APPSAT:CSAT AT ratio 
 APPSAT:TSAT AT ratio 
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Figures 
Figure 1. Generation of stage-specific adiposity profiles in zebrafish. A. 
Fluorescence stereomicroscope images of Nile Red stained zebrafish at two distinct 
postembryonic stages (PR and SA). Note the increasingly complex and diversifying 
distribution patterns of AT in SA fish relative to PR. White arrows correspond to pDSAT 
(posterior dorsal SAT), black arrowheads correspond to cPOS (central paraosseal), and 
white arrowheads correspond to AFRSAT (anal fin ray SAT). B. To determine wild-type 
adiposity dynamics, 67 adiposity traits were measured in 456 wild-type zebrafish. PB 
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denotes the pectoral fin bud stage from Parichy et al (2009). Each stage consisted of >10 
fish. For each stage, inter-trait correlations were determined and used to create an 
adiposity profile that encapsulates relationship dynamics of individual ATs. C. Example 
inter-trait correlations are given for PVAT (pancreatic VAT) and demonstrate the changing 
relationship between PVAT and standard length (SL) across distinct stages.  
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Figure 2. Linear discriminant analysis can be used to identify and classify 
phenotypic fish based on adiposity profiles. A. Linear discriminant analysis (LDA) was 
used as a training set to classify 456 wild-type fish according to stage-specific adiposity 
profiles. From this training set, LDA was able to accurately classify fish based on adiposity 
profiles in 87.5% of instances. B. Zebrafish homozygous for the growth hormone (gh) 
wp22e1 mutation have increased total AT (dotted outlines delineate AT). C. Quantification 
of total AT area in wild-type sibling and gh mutants. Student’s t-test, *** = P<0.0001. D. 
Schematic detailing how the linear discriminant analysis was used to analyse gh mutant 
and wild-type (WT) sibling fish relative to the training set. E. Of the 122 gh and WT sibling 
fish, linear discriminant analysis detected 36% as phenotypic (all). The WT sibling fish 
were not classified as phenotypic relative to baseline classification from the training set 
(WT). The gh homozygous mutant fish were classified as phenotypic in 60% instances.    
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Figure 3. Linear discriminant analysis can be used as a screening tool to identify 
mutants with adiposity phenotypes in zebrafish. A. LDA misclassification rates (% 
phenotypic fish) for the eight ZMP mutants, gh mutants (positive control) and the wild-
type training set. Error bars denote the standard error from the mean across multiple 
clutches. Bars without error bars are from single clutches. Details of the alleles for each 
mutant line can be found in Table 1. B. Fluorescence stereomicroscope images of Nile 
Red stained wild-type sibling and two nrp2bsa18942 homozygous mutant zebrafish. Note 
the reduced adiposity levels in nrp2bsa18942 mutants. C. Two additional independent 
clutches of wild-type siblings and nrp2bsa18942 mutants were assessed to validate the 
nrp2b phenotype. Linear regression (straight lines with 95% confidence intervals noted) 
was used to evaluate adiposity relative to SL, and ANCOVA was used to test for 
differences between the groups. F1,83 = 52.4, P < 0.0001.   
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Figure 4. Food restriction and subsequent re-feeding leads to changes in adipose 
distribution. A. Fluorescence stereomicroscope images of Nile Red stained zebrafish 
reveal the mobilization and reduction of lipid within adipose tissue during 11 days of food 
restriction (magenta, days 1-11), and the re-deposition and increase in lipid within adipose 
during 11 days of re-feeding (blue, days 12-22). B. Principal components analysis of 
adiposity traits during food restriction and re-feeding reveals that food restriction leads to 
altered adipose distribution. Note that fed fish (light magenta, day 1) do not co-localize 
with re-fed animals (dark blue, day 22). C. Principal components analysis of food 
restriction and re-feeding reveals the daily changes in adipose distribution. 
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Figure 5. Linear discriminant analysis can be used to classify food restriction-
induced changes in adiposity. A. Chart showing the reduction and subsequent re-gain 
of total AT area during food restriction (days 1-11) and re-feeding (days 12-22). Black line 
connects the mean total AT area at each day. Black error bars at each day denote the 
standard deviation in total AT area. Grey lines indicate the total AT area of individual fish. 
Red bars indicate the standard deviation of total AT area of size-matched fed animals. 
Note that at day 22, re-fed animals have re-gained total AT to an equivalent level as size-
matched continuously fed animals. B. Adiposity profiles showing inter-trait correlations at 
stage DFRSAT in food restricted/re-fed animals and size-matched continuously fed 
animals. C. Linear discriminant analysis classifies food restricted/re-fed animals as 
phenotypic in 90% of instances. 
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Figure 6. Internal adipose tissues have a decreased capacity to replenish lipid 
stores following food restriction. A. Hierarchical clustering of individual ATs based on 
% replenishment of lipid (day 22 lipid as a % of day 1 lipid). Four clusters were identified 
(#1-4) and ranked according to replenishment rates. Colour-code indicates % lipid 
replenishment (purple/blue = low, green/red = high). Internal ATs (IAT) are coloured 
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magenta. SAT are coloured green, and non-AT measures (e.g., SL) are coloured black. 
Pie charts depict the proportion of AT types in each cluster. Note, that clusters that 
replenish lipid to a high degree (i.e., clusters #3 & 4) and increasingly composed of SATs. 
B,C. AT-lipid mobilization and replenishment dynamics over the course of food-restriction 
(days 1-11) and re-feeding (days 12-22). The black line links mean AT area values at 
each timepoint. The black error bars denote standard deviation around the mean at each 
timepoint. The grey lines denote each individual fish (N = 10). The red (IAT; B) or green 
(SAT; C) bars denote the standard deviation around the mean of size & stage-matched 
‘continuously-fed’ wild-type fish. These bars represent the expected IAT and SAT 
quantities in ‘normal’ fish. Note, that IAT after food restriction and re-feeding does not 
recover to expected wild-type levels. D. The % recovery of IAT and SAT reveals 
significant differences between the distinct AT divisions. E. The IAT:SAT ratio is 
significantly reduced in food restricted and re-fed animals (day 22) when compared to 
size and stage-matched ‘continuously-fed’ fish.  
